IGC Pharma, Inc. IGC
$0.30
+1.29%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $5.50
- Implied Upside
- +1746.9%
- Price Target Range
- $5.50 – $5.50
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-08 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $6 |
| 2026-04-08 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $5 |
| 2026-02-23 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $5 |
| 2025-12-09 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $5 → $5 |
| 2025-08-26 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $4 → $5 |
| 2025-03-06 | Alliance Global PartnersJames Molloy |
Reiterates | Buy | $4 |
| 2025-02-24 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $4 → $4 |
| 2024-12-05 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $4 → $4 |
| 2024-09-03 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $4 → $4 |
| 2024-07-29 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $3 → $4 |
| 2024-07-17 | Alliance Global PartnersJames Molloy |
Initiates coverage on | Buy | $4 |
| 2024-06-21 | Ascendiant CapitalEdward Woo |
Reiterates | Buy | $3 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.30
- Market Cap
- $29.84 million
- 52-Week Range
- $0.23 – $0.50
- Average Volume
- 599K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.